News

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.

Friday, December 6, 2013
Pictured: Casper zebrafish
Transparent Fish Reveal Secrets of Tumor Spread

Physician and cell biologist Richard White has generated a transparent and stripeless strain of zebrafish to study how tumors develop the capacity to metastasize to new organs.

Tuesday, December 3, 2013
Pictured: Joan Massagué
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.

Monday, November 25, 2013
Study Reveals Genetic Causes for Thyroid Cancer Increase after Chernobyl

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

Wednesday, November 13, 2013
Pictured: Sarat Chandarlapaty
Researchers Identify Mutations that Cause Some Breast Cancers to Resist Treatment

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Friday, November 8, 2013
Pictured: Stephen Long & Alexandria Miller
At Work: Structural Biologist Stephen Long

Stephen Long works to understand how proteins work by determining what they look like in three dimensions.

Thursday, November 7, 2013
Pictured: Craig Thompson
Watch Live Webcast of “Major Trends” Seminar — Annual Event for High School Students

Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.

Monday, November 4, 2013
Pictured: Emily Foley
At Work: Cell Biologist Emily Foley

Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.

Friday, October 18, 2013
Mouse glioblastoma tumor with phagocytic macrophages
Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

Tuesday, October 15, 2013
Breast cancer mosaic
New Technology Could Enable Immediate Detection of Tumor Borders during Surgery

Memorial Sloan Kettering scientists are developing new imaging instrumentation that could enable pathologist and surgeons to collaborate more seamlessly and reduce the need for repeat surgeries.

Wednesday, October 9, 2013